Cancer treatment

Illumina Ordered by FTC to Unwind $7B Grail Deal From 2021

Grail was spun off from DNA-sequencing giant Illumina in 2016 to develop a blood test to detect 50 types of early stages of cancer.

April 3, 2023

The purchase is part of Merck’s search for more treatments for cancer and rare diseases.

November 21, 2022

Apollomics is working on nine types of drugs for difficult-to-treat forms of lung cancer and leukemia.

September 14, 2022

LumaBridge operates as a strategic partner to biopharma and biotech firms and offers outsourced clinical trial support.

August 24, 2022

Bristol Myers will pay $76 a share in cash to acquire all outstanding Turning Point shares.

June 3, 2022

The investment will support OncoHealth's delivery of its digital health services for cancer patients.

May 9, 2022

The organization is a provider of cancer treatment services with over 30 providers.

April 22, 2022

VO is committed to the development and commercialization of new medicines to improve the lives of cancer patients.

March 28, 2022